Merck Wins Another FOSAMAX State Court Trial

by Benzinga Staff
April 18, 2012 3:43 PM | 27 seconds read

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Merck (NYSE: MRK) today said a state court jury in New Jersey found in its favor in the Sessner v. Merck case, rejecting the claims of a woman who blamed her jaw-related problems on her FOSAMAX use. With today's verdict, Merck won the second state court case to go to trial in the coordinated New Jersey FOSAMAX litigation. The plaintiff in this case alleged she used FOSAMAX from 2002 to 2008 and that she suffered various jaw problems and complications following the extraction of four teeth in October 2007.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsLegal

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.